Drugs / Toca 511 vector
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01156584 | Jul 2010 → Aug 2016 | anaplastic astrocytoma, anaplastic oligoastrocytoma, anaplastic oligodendroglioma, glioblastoma | Tocagen Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Toca 511 vector | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01156584 ↗ |
| Route | Other | “intratumoral injection” NCT01156584 ↗ |